Jan-Åke Gustafsson Selected Research

cholestenoic acid

1/2019	Concentrations of bile acid precursors in cerebrospinal fluid of Alzheimer's disease patients.
11/2014	Cholestenoic acids regulate motor neuron survival via liver X receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jan-Åke Gustafsson Research Topics

Disease

35	Neoplasms (Cancer) 01/2021 - 04/2011
21	Breast Neoplasms (Breast Cancer) 10/2019 - 01/2011
12	Prostatic Neoplasms (Prostate Cancer) 10/2021 - 12/2011
11	Inflammation (Inflammations) 11/2021 - 08/2011
8	Obesity 01/2021 - 01/2012
7	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 06/2011
7	Neoplasm Metastasis (Metastasis) 10/2020 - 11/2012
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 05/2012
6	Carcinogenesis 11/2020 - 06/2011
6	Insulin Resistance 01/2020 - 07/2011
6	Hypoxia (Hypoxemia) 11/2018 - 02/2014
5	Atherosclerosis 01/2022 - 07/2012
5	Fatty Liver 01/2019 - 08/2013
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 09/2011
5	Non-alcoholic Fatty Liver Disease 01/2017 - 11/2012
4	Triple Negative Breast Neoplasms 01/2018 - 03/2016
3	Multiple Sclerosis 11/2021 - 09/2011
3	Hyperplasia 01/2020 - 01/2016
3	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 05/2011
3	Carcinoma (Carcinomatosis) 11/2018 - 12/2012
3	Body Weight (Weight, Body) 01/2018 - 01/2013
3	Diabetes Insipidus 01/2017 - 02/2012
3	Colonic Neoplasms (Colon Cancer) 07/2016 - 06/2011
2	Demyelinating Diseases (Demyelinating Disease) 05/2022 - 01/2012
2	Atherosclerotic Plaque (Atheroma) 01/2022 - 04/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2020 - 11/2020
2	Colitis 11/2020 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2012
2	Infections 01/2017 - 02/2016
2	Fibrosis (Cirrhosis) 01/2017 - 03/2016
2	Metabolic Diseases (Metabolic Disease) 06/2015 - 01/2012
2	Inborn Genetic Diseases (Disease, Hereditary) 11/2014 - 12/2012
2	Parkinson Disease (Parkinson's Disease) 02/2013 - 08/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2012 - 09/2011
2	Hypertrophy 04/2011 - 03/2011
1	Neuroinflammatory Diseases 11/2021
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2021
1	Neural Tube Defects (Exencephaly) 01/2021
1	Epilepsy (Aura) 01/2021
1	Congenital Abnormalities (Deformity) 01/2021
1	Hereditary Spastic Paraplegia 12/2019

Drug/Important Bio-Agent (IBA)

33	Estrogen ReceptorsIBA 10/2020 - 01/2011
21	Liver X ReceptorsIBA 01/2022 - 05/2011
16	CholesterolIBA 01/2022 - 05/2011
16	Estrogens (Estrogen)FDA Link 11/2020 - 04/2011
14	LigandsIBA 12/2020 - 09/2011
12	Proteins (Proteins, Gene)FDA Link 09/2017 - 01/2011
11	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 07/2011
11	Estrogen Receptor betaIBA 11/2020 - 03/2011
10	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021 - 08/2011
6	LipidsIBA 11/2020 - 09/2011
6	Hormones (Hormone)IBA 11/2020 - 07/2011
5	Biological ProductsIBA 01/2020 - 07/2011
4	OxysterolsIBA 12/2019 - 04/2016
4	Pharmaceutical PreparationsIBA 10/2019 - 10/2012
4	Estrogen Receptor alphaIBA 01/2019 - 01/2013
4	GW 3965IBA 09/2016 - 01/2013
3	Protein Isoforms (Isoforms)IBA 11/2021 - 09/2016
3	AndrogensIBA 10/2021 - 11/2018
3	Transcription Factors (Transcription Factor)IBA 11/2020 - 08/2011
3	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2017
3	Bile Acids and Salts (Bile Acids)IBA 12/2019 - 11/2012
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 09/2015
3	Tamoxifen FDA LinkGeneric 12/2015 - 04/2011
3	Phytoestrogens (Phytoestrogen)IBA 03/2014 - 01/2011
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
2	AzoxymethaneIBA 11/2020 - 01/2019
2	Therapeutic UsesIBA 08/2020 - 01/2018
2	erteberelIBA 08/2020 - 01/2018
2	Progesterone Receptors (Progesterone Receptor)IBA 10/2019 - 09/2015
2	cholestenoic acidIBA 01/2019 - 11/2014
2	SterolsIBA 01/2019 - 01/2017
2	bisphenol AIBA 01/2019 - 03/2014
2	Amyloid (Amyloid Fibrils)IBA 01/2019 - 05/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 12/2013
2	Phenobarbital (Luminal)FDA Link 04/2018 - 07/2017
2	Glutathione PeroxidaseIBA 01/2017 - 12/2013
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 07/2013
2	Triglycerides (Triacylglycerol)IBA 12/2016 - 08/2013
2	EnzymesIBA 10/2016 - 11/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016 - 01/2015
2	ChromatinIBA 09/2015 - 06/2011
2	CateninsIBA 01/2015 - 01/2012
2	Cadherins (E-Cadherin)IBA 07/2013 - 11/2012
2	Estradiol (Delestrogen)FDA LinkGeneric 09/2011 - 03/2011
2	Tetracycline (Achromycin)FDA LinkGeneric 04/2011 - 01/2011
1	Glutamic Acid (Glutamate)FDA Link 05/2022
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 05/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021
1	Testosterone (Sustanon)FDA Link 01/2021
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2021
1	Glutamine (L-Glutamine)FDA Link 12/2020
1	Mutant Proteins (Protein, Mutant)IBA 11/2020
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2020
1	Dextrans (Dextran)FDA Link 11/2020
1	phosphatidylinositol-3,4-bisphosphate 4-phosphataseIBA 10/2020
1	Immune Checkpoint InhibitorsIBA 08/2020

Therapy/Procedure

13	Therapeutics 01/2021 - 04/2011
3	Drug Therapy (Chemotherapy) 11/2018 - 01/2018
1	Immunotherapy 08/2020